Immune Reconstitution and Safe Metabolic Profile after the Switch to Bictegravir/Emtricitabine/Tenofovir Alafenamide Fumarate among Virologically Controlled PLWH: A 96 Week Update from the BICTEL Cohort
Alessandro Lazzaro(Policlinico Umberto I), Gabriella d’Ettorre(Policlinico Umberto I), Claudio Maria Mastroianni(Sapienza University of Rome), Ginevra Bugani(Sapienza University of Rome), Giancarlo Ceccarelli(International Organization for Migration), Caterina Fimiani(Policlinico Umberto I), Ivano Mezzaroma(Istituto Superiore di Sanità), Luca Maddaloni(Sapienza University of Rome), Carolina Andreoni(Sapienza University of Rome), Mario Falciano(Policlinico Umberto I), Elio Gentilini Cacciola(Sapienza University of Rome), Diana Bianchini(Policlinico Umberto I), Letizia Santinelli(Sapienza University of Rome)
Cited by 12
Related Papers
Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by<i>Klebsiella pneumoniae</i>Carbapenemase–producing<i>K. pneumoniae</i>
|Clinical Infectious Diseases|2018|351
Post-Traumatic Stress Symptoms in Healthcare Workers Dealing with the COVID-19 Pandemic: A Systematic Review
|International Journal of Environmental Research and Public Health|2021|272
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase–Producing <i>K. pneumoniae</i> Infections: A Retrospective Observational Multicenter Study
|Clinical Infectious Diseases|2021|264